Literature DB >> 20339118

Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.

Augusto C Montezano1, Dylan Burger, Tamara M Paravicini, Andreia Z Chignalia, Hiba Yusuf, Mahmoud Almasri, Ying He, Glaucia E Callera, Gang He, Karl-Heinz Krause, David Lambeth, Mark T Quinn, Rhian M Touyz.   

Abstract

RATIONALE: Although Nox5 (Nox2 homolog) has been identified in the vasculature, its regulation and functional significance remain unclear.
OBJECTIVES: We sought to test whether vasoactive agents regulate Nox5 through Ca(2+)/calmodulin-dependent processes and whether Ca(2+)-sensitive Nox5, associated with Rac-1, generates superoxide (O(2)(*-)) and activates growth and inflammatory responses via mitogen-activated protein kinases in human endothelial cells (ECs). METHODS AND
RESULTS: Cultured ECs, exposed to angiotensin II (Ang II) and endothelin (ET)-1 in the absence and presence of diltiazem (Ca(2+) channel blocker), calmidazolium (calmodulin inhibitor), and EHT1864 (Rac-1 inhibitor), were studied. Nox5 was downregulated with small interfering RNA. Ang II and ET-1 increased Nox5 expression (mRNA and protein). Effects were inhibited by actinomycin D and cycloheximide and blunted by diltiazem, calmidazolium and low extracellular Ca(2+) ([Ca(2+)](e)). Ang II and ET-1 activated NADPH oxidase, an effect blocked by low [Ca(2+)](e), but not by EHT1864. Nox5 knockdown abrogated agonist-stimulated O(2)(*-) production and inhibited phosphorylation of extracellular signal-regulated kinase (ERK)1/2, but not p38 MAPK (mitogen-activated protein kinase) or SAPK/JNK (stress-activated protein kinase/c-Jun N-terminal kinase). Nox5 small interfering RNA blunted Ang II-induced, but not ET-1-induced, upregulation of proliferating-cell nuclear antigen and vascular cell adhesion molecule-1, important in growth and inflammation.
CONCLUSIONS: Human ECs possess functionally active Nox5, regulated by Ang II and ET-1 through Ca(2+)/calmodulin-dependent, Rac-1-independent mechanisms. Nox5 activation by Ang II and ET-1 induces ROS generation and ERK1/2 phosphorylation. Nox5 is involved in ERK1/2-regulated growth and inflammatory signaling by Ang II but not by ET-1. We elucidate novel mechanisms whereby vasoactive peptides regulate Nox5 in human ECs and demonstrate differential Nox5-mediated functional responses by Ang II and ET-1. Such phenomena link Ca(2+)/calmodulin to Nox5 signaling, potentially important in the regulation of endothelial function by Ang II and ET-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339118      PMCID: PMC3119893          DOI: 10.1161/CIRCRESAHA.109.216036

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  47 in total

Review 1.  Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.

Authors:  Hideki Sumimoto
Journal:  FEBS J       Date:  2008-05-30       Impact factor: 5.542

2.  NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression.

Authors:  D Komatsu; M Kato; J Nakayama; S Miyagawa; T Kamata
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

3.  Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.

Authors:  Fatiha Tabet; Ernesto L Schiffrin; Glaucia E Callera; Ying He; Guoying Yao; Arne Ostman; Kai Kappert; Nicholas K Tonks; Rhian M Touyz
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

4.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

Review 5.  Differential vascular functions of Nox family NADPH oxidases.

Authors:  Ralf P Brandes; Katrin Schröder
Journal:  Curr Opin Lipidol       Date:  2008-10       Impact factor: 4.776

6.  Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha.

Authors:  Lucia S Yoshida; Shohko Tsunawaki
Journal:  Int Immunopharmacol       Date:  2008-06-04       Impact factor: 4.932

7.  Phosphatidylinositol (4,5)-bisphosphate modulates Nox5 localization via an N-terminal polybasic region.

Authors:  Tsukasa Kawahara; J David Lambeth
Journal:  Mol Biol Cell       Date:  2008-07-09       Impact factor: 4.138

8.  Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase.

Authors:  Qian Zhang; Pulkit Malik; Deepesh Pandey; Sonali Gupta; Davin Jagnandan; Eric Belin de Chantemele; Botond Banfi; Mario B Marrero; R Daniel Rudic; David W Stepp; David J R Fulton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

9.  Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease.

Authors:  Tomasz J Guzik; Wei Chen; Maria C Gongora; Bartlomiej Guzik; Heinrich E Lob; Deepa Mangalat; Nyssa Hoch; Sergey Dikalov; Pawel Rudzinski; Boguslaw Kapelak; Jerzy Sadowski; David G Harrison
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

10.  Regulation of ROS signal transduction by NADPH oxidase 4 localization.

Authors:  Kai Chen; Michael T Kirber; Hui Xiao; Yu Yang; John F Keaney
Journal:  J Cell Biol       Date:  2008-06-23       Impact factor: 10.539

View more
  62 in total

Review 1.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

Review 2.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

Review 3.  Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.

Authors:  Aurelie Nguyen Dinh Cat; Augusto C Montezano; Dylan Burger; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

Review 4.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 5.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 6.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

7.  Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4.

Authors:  Katherine J Massey; Nancy J Hong; Jeffrey L Garvin
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-08       Impact factor: 4.249

8.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

Review 10.  Oxidative stress, NADPH oxidases, and arteries.

Authors:  Qi-An Sun; Marschall S Runge; Nageswara R Madamanchi
Journal:  Hamostaseologie       Date:  2015-02-04       Impact factor: 1.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.